Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-9190 for neuromuscular blockade during anesthesia induction (phase II)
CTR20254160Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-9190 in None, sponsored by Hengrui Therapeutics. Started Oct 2025; status: completed.
02
Drugs
HRS-9190
Beyond the preview
Go deeper on CTR20254160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254160.